L13 Interstitial Lung disease Flashcards
Diffuse Parenchymal Lung Disease aka
Interstitial lung disease
honeycombing
clustered cystic air spaces
Interstitial lung disease pathophysiology
Extension distortion of the airway and alveolar compartment along with the interstitium causing progressive scarring of lung tissue surrounding the alveoli
Areas of fibrosis alternate with areas of normal lung
Honeycombing
Causes of Interstitial lung disease
Idiopathic
Autoimmune
Exposure
Drugs
exposure causes
asbestos, silica, bat/bird droppings, radiation, hot tubs
drug causes
amiodarone propranolol nitrofurantoin methotrexate rituximab
autoimmune causes
dermatomyositis,RA, scleroderma, sarcoidosis, sjogrens
Interstitial lung disease is ______ so the treatment goal is to ______
IRREVERSIBLE
prevent progression/alleviate sx
what symptoms are uncommon in Interstitial lung disease
wheezing, chest pain
main sx of Interstitial lung disease
Progressive dyspnea on exertion
Persistent non-productive cough
extra-pulmonary symptoms may indicate
connective tissue disease→ musculoskeletal pain, weakness, joint pain/swelling, fevers, dry eyes/mouth
heard on lung exam of a patient with Interstitial lung disease
velcro crackles at bases
inspiratory squeaks
late stage Interstitial lung disease signs
cyanosis, digital clubbing cor pulmonale (middle/late)
Extrapulmonary manifestations: erythema nodosum
Sarcoidosis
Extrapulmonary manifestations: gottron’s papules
Dermatomyositis
highest yield for noninvasive test to diagnose Interstitial lung disease
High resolution chest CT (HRCT)
Gold standard to diagnose Interstitial lung disease
Tissue biopsy
findings on CXR that could indicate Interstitial lung disease
Ground glass appearance early, nonspecific
Reticular “netlike” (most common), nodular, or mixed pattern of opacities
Honeycombing: small cystic spaces: poor prognosis
reticular opacities are
small irregular opacities
Micronodular pattern is
small rounded opacities
HRCT: reticular opacities
IPF
Asbestosis
HRCT: ground glass attenuation
Drug toxicity
Respiratory bronchiolitis
HRCT: upper/central lobes
Sarcoidosis
Serologic studies to rule out subclinical autoimmune disease
ANA, RF
when to evaluate for vasculitis and how
pulmonary hemorrhage or suspicious systemic symptoms
Antineutrophil cytoplasmic antibodies (ANCA)
signs of restrictive disease on PFTs
Decreased Total lung capacity
Decreased FEV1, FVC
Normal/increased FEV1/FVC
PFTs obstructive disease
Increased TLCC
Normal FVC
Decreased FEV1
Decreased FEV1/FVC ratio
If PFTs indicate restrictive disease, obtain
DLCO: low=ILD
ILD with obstructive pattern
sarcoidosis
Extension of bronchoscopy that allows sampling→ cell counts, culture (atypical/typical), cytology (identify maligancy)
Bronchoalveolar lavage